Concepedia

Chie Hatori

CH

16

Publications

820

Citations

16

H-Index

1997

Active since

Affiliations

Fujisawa City Hospital(Current)

Astellas Pharma (Japan)

Mochida Pharmaceutical (Japan)

Chie Hatori is an author at Fujisawa City Hospital specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

1997–2011

16

Publications

16

Discovery of the First Non-Peptide Full Agonists for the Human Bradykinin B<sub>2</sub>Receptor Incorporating 4-(2-Picolyloxy)quinoline and 1-(2-Picolyl)benzimidazole Frameworks

Yuki Sawada, Hiroshi Kayakiri, Yoshito Abe et al. · Journal of Medicinal Chemistry · 2004 · 113 citations · Full text

The identification of an orally active, nonpeptide bradykinin B<sub>2</sub> receptor antagonist, FR173657

Masayuki Asano, Noriaki Inamura, Chie Hatori et al. · British Journal of Pharmacology · 1997 · 108 citations · Full text

A Novel Class of Orally Active Non-Peptide Bradykinin B<sub>2</sub> Receptor Antagonists. 1. Construction of the Basic Framework

Yoshito Abe, Hiroshi Kayakiri, Shigeki Satoh et al. · Journal of Medicinal Chemistry · 1998 · 91 citations · Full text

, , +18

A Novel Class of Orally Active Non-Peptide Bradykinin B<sub>2</sub> Receptor Antagonists. 3. Discovering Bioisosteres of the Imidazo[1,2-<i>a</i>]pyridine Moiety

Yoshito Abe, Hiroshi Kayakiri, Shigeki Satoh et al. · Journal of Medicinal Chemistry · 1998 · 79 citations · Full text

, , +16

A Novel Class of Orally Active Non-Peptide Bradykinin B<sub>2</sub> Receptor Antagonists. 4. Discovery of Novel Frameworks Mimicking the Active Conformation

Yoshito Abe, Hiroshi Kayakiri, Shigeki Satoh et al. · Journal of Medicinal Chemistry · 1998 · 62 citations · Full text

, , +17

Rows per page

1–5 of 16